000 | 02007 a2200589 4500 | ||
---|---|---|---|
005 | 20250517100503.0 | ||
264 | 0 | _c20160906 | |
008 | 201609s 0 0 eng d | ||
022 | _a0261-1929 | ||
024 | 7 |
_a10.1177/026119291604400206 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBehrsing, Holger | |
245 | 0 | 0 |
_aAssessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model use. _h[electronic resource] |
260 |
_bAlternatives to laboratory animals : ATLA _cMay 2016 |
||
300 |
_a129-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimal Experimentation |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aGoblet Cells _xpathology |
650 | 0 | 4 | _aGovernment Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMucociliary Clearance _xphysiology |
650 | 0 | 4 |
_aMucus _xmetabolism |
650 | 0 | 4 |
_aNicotine _xadverse effects |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xetiology |
650 | 0 | 4 |
_aTobacco Products _xadverse effects |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aRaabe, Hans | |
700 | 1 | _aManuppello, Joseph | |
700 | 1 | _aBombick, Betsy | |
700 | 1 | _aCurren, Rodger | |
700 | 1 | _aSullivan, Kristie | |
700 | 1 | _aSethi, Sanjay | |
700 | 1 | _aPhipps, Richard | |
700 | 1 | _aTesfaigzi, Yohannes | |
700 | 1 | _aYan, Sherwin | |
700 | 1 | _aD'Ruiz, Carl | |
700 | 1 | _aTarran, Robert | |
700 | 1 | _aConstant, Samuel | |
700 | 1 | _aPhillips, Gary | |
700 | 1 | _aGaça, Marianna | |
700 | 1 | _aHayden, Patrick | |
700 | 1 | _aCao, Xuefei | |
700 | 1 | _aMathis, Carole | |
700 | 1 | _aHoeng, Julia | |
700 | 1 | _aBraun, Armin | |
700 | 1 | _aHill, Erin | |
773 | 0 |
_tAlternatives to laboratory animals : ATLA _gvol. 44 _gno. 2 _gp. 129-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/026119291604400206 _zAvailable from publisher's website |
999 |
_c26086191 _d26086191 |